Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT04773769
Eligibility Criteria:
Inclusion Criteria:
* Understand and voluntarily sign an informed consent form.
* Age \> 18 years at the time of signing the informed consent form.
* Willing and able to adhere to the study visit schedule and other protocol requirements.
* Must have measurable or evaluable disease.
* All previous cancer therapy, including radiation, hormonal therapy and surgery, must have been discontinued at least 2 weeks prior to treatment in this study.
* Performance status of ≤ 2 on the Eastern Cooperative Oncology Group (ECOG) scale at study entry.
Exclusion Criteria:
* Patients actively taking guanabana or guanabana tea daily or who have used it at some point after their diagnosis of cancer.
* Patients with Parkinson's disease.
* Serum Total Bilirubin ≥ 3.0 mg/dL
* Serum Creatinine level ≥ 3.0 mg/dL
* Central Nervous System (CNS) involvement.
* Known human immunodeficiency virus (HIV) infection; Known active hepatitis B or hepatitis C infection.
* Females who are pregnant (positive urine test) or breast-feeding females.
* Any history of a medical condition or a concomitant medical condition that, in the opinion of the investigator, would compromise the subject's ability to safely complete the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04773769
Study Brief:
Protocol Section:
NCT04773769